× Industry Reports Services Press Release Contact us About us

Europe In Vitro Diagnostics (IVD) Market Forecast 2027 By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics), By Product Type (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay/ Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By End-Use (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), Research Report, Country Outlook (Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Poland, Denmark, Sweden, Finland, Norway), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: January 2022 | Publisher: Graphical Research Report ID: GR1019 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definition

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Europe in vitro diagnostics industry summary, 2016 – 2027

2.1.1    Business trends

2.1.2    Product type trends

2.1.3    Test type trends

2.1.4    Application trends

2.1.5    End-use trends

2.1.6    Regional trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2016 – 2027

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1    Rising incidence of growth disorders

3.3.1.2    Growing R&D activities in growth hormone industry

3.3.1.3    Rising awareness about the synthetic growth hormone therapy in developing regions

3.3.2    Restraints & challenges

3.3.2.1    High cost of synthetic growth hormone treatment

3.3.2.2    Side effects associated with use of synthetic growth hormones

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Chapter 4   Europe In Vitro Diagnostics Market, By Product Type

4.1    Key trends in Europe in Vitro Diagnostics Market, by product type

4.2    Reagents & Kits

4.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

4.3    Instruments

4.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 5   Europe In Vitro Diagnostics Market, By Test Type

5.1    Key trends in Europe in vitro diagnostics market, by test type

5.2    Clinical chemistry

5.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.3    Immunoassay/Immunochemistry

5.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.4    Molecular diagnostics

5.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.5    Hematology

5.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.6    Urinalysis

5.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

5.7    Others

5.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 6   Europe In Vitro Diagnostics Market, By Application

6.1    Key trends in Europe in vitro diagnostics market, by application

6.2    Oncology

6.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.3    Infectious diseases

6.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.4    Diabetes

6.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.5    Cardiology

6.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.6    Nephrology

6.6.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.7    Autoimmune Diseases

6.7.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.8    Drug Testing/Pharmacogenomics

6.8.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

6.9    Others

6.9.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 7   Europe In Vitro Diagnostics Market, By End-use

7.1    Key trends in Europe in vitro diagnostics market, by end-use

7.2    Hospitals

7.2.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.3    Diagnostic laboratories

7.3.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.4    Academic & research institutes

7.4.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2016-2027 (USD Million)

Chapter 8   Europe In Vitro Diagnostics Market, By Country

8.1    Key trends in Europe in Vitro diagnostics market, by country

8.1.1    Germany

8.1.1.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.1.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.1.3    Market estimates and forecast, by application, 2016 – 2027

8.1.1.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.2    France

8.1.2.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.2.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.2.3    Market estimates and forecast, by application, 2016 – 2027

8.1.2.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.3    UK

8.1.3.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.3.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.3.3    Market estimates and forecast, by application, 2016 – 2027

8.1.3.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.4    Italy

8.1.4.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.4.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.4.3    Market estimates and forecast, by application, 2016 – 2027

8.1.4.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.5    Spain

8.1.5.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.5.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.5.3    Market estimates and forecast, by application, 2016 – 2027

8.1.5.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.6    Netherland

8.1.6.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.6.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.6.3    Market estimates and forecast, by application, 2016 – 2027

8.1.6.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.7    Switzerland

8.1.7.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.7.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.7.3    Market estimates and forecast, by application, 2016 – 2027

8.1.7.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.8    Poland

8.1.8.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.8.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.8.3    Market estimates and forecast, by application, 2016 – 2027

8.1.8.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.9    Denmark

8.1.9.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.9.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.9.3    Market estimates and forecast, by application, 2016 – 2027

8.1.9.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.10    Sweden

8.1.10.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.10.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.10.3    Market estimates and forecast, by application, 2016 – 2027

8.1.10.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.11    Finland

8.1.11.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.11.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.11.3    Market estimates and forecast, by application, 2016 – 2027

8.1.11.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.12    Norway

8.1.12.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.12.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.12.3    Market estimates and forecast, by application, 2016 – 2027

8.1.12.4    Market estimates and forecast, by end-use, 2016 – 2027

8.1.13    Others

8.1.13.1    Market estimates and forecast, by product type, 2016 – 2027

8.1.13.2    Market estimates and forecast, by test type, 2016 – 2027

8.1.13.3    Market estimates and forecast, by application, 2016 – 2027

8.1.13.4    Market estimates and forecast, by end-use, 2016 – 2027

Chapter 9   Company Profiles

9.1    F. Hoffmann-La Roche AG

9.1.1    Business Overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Abbott

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.3    Danaher

9.3.1    Business Overview

9.3.2    Financial data

9.3.3    Product Landscape

9.4    Siemens Healthineers

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.5    BioMerieux

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    DiaSorin

9.6.1    Business Overview

9.6.2    Financial data

9.6.3    Product landscape

9.7    Bio-Rad Laboratories

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.8    Sysmex Corporation

9.8.1    Business Overview

9.8.2    Financial data

9.8.3    Product Landscape

9.9    Thermo Fisher Scientific

9.9.1    Business Overview

9.9.2    Financial data

9.9.3    Product Landscape

9.9.4    Strategy outlook

9.10    Qiagen

9.10.1    Business Overview

9.10.2    Financial data

9.10.3    Product Landscape

9.11    Ortho Clinical Diagnostics

9.11.1    Business Overview

9.11.2    Financial data

9.11.3    Product Landscape

9.12    Becton, Dickinson and Company.

9.12.1    Business Overview

9.12.2    Financial data

9.12.3    Product Landscape
 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]